{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:54:35Z","timestamp":1789901675808,"version":"4.0.1"},"reference-count":67,"publisher":"American Society for Microbiology","issue":"24","license":[{"start":{"date-parts":[[2003,12,15]],"date-time":"2003-12-15T00:00:00Z","timestamp":1071446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2003,12,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>West Nile virus (WNV) is a mosquito-borne<jats:italic>Flavivirus<\/jats:italic>that causes encephalitis in a subset of susceptible humans. Current treatment for WNV infections is supportive, and no specific therapy or vaccine is available. In this study, we directly tested the prophylactic and therapeutic efficacy of polyclonal antibodies against WNV. Passive administration of human gamma globulin or mouse serum prior to WNV infection protected congenic wild-type, B-cell-deficient (\u03bcMT), and T- and B-cell-deficient (<jats:italic>RAG1<\/jats:italic>) C57BL\/6J mice. Notably, no increased mortality due to immune enhancement was observed. Although immune antibody completely prevented morbidity and mortality in wild-type mice, its effect was not durable in immunocompromised mice: many \u03bcMT and<jats:italic>RAG1<\/jats:italic>mice eventually succumbed to infection. Thus, antibody by itself did not completely eliminate viral reservoirs in host tissues, consistent with an intact cellular immune response being required for viral clearance. In therapeutic postexposure studies, human gamma globulin partially protected against WNV-induced mortality. In \u03bcMT mice, therapy had to be initiated within 2 days of infection to gain a survival benefit, whereas in the wild-type mice, therapy even 5 days after infection reduced mortality. This time point is significant because between days 4 and 5, WNV was detected in the brains of infected mice. Thus, passive transfer of immune antibody improves clinical outcome even after WNV has disseminated into the central nervous system.<\/jats:p>","DOI":"10.1128\/jvi.77.24.12941-12949.2003","type":"journal-article","created":{"date-parts":[[2003,11,25]],"date-time":"2003-11-25T22:59:20Z","timestamp":1069801160000},"page":"12941-12949","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":152,"title":["Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMice"],"prefix":"10.1128","volume":"77","author":[{"given":"Michael J.","family":"Engle","sequence":"first","affiliation":[{"name":"Departments of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[{"name":"Departments of Medicine"},{"name":"Pathology &amp; Immunology"},{"name":"Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/376871"},{"key":"e_1_3_2_3_2","first-page":"44","volume":"43","year":"1968","unstructured":"Albrecht, P. 1968. Pathogenesis of neurotropic arbovirus infections. Curr. Top. Microbiol. Immunol.43:44-91.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1476-5586(03)80006-4"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0801.010252"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/313737"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-11-2539"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/376870"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-2-229"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<259::AID-JMV13>3.0.CO;2-M"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.57.3.952-959.1986"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.1.258"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00360-0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9357"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-11-2811"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.11.4957-4966.2000"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.17.7814-7823.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.4.2578-2586.2003"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0704.017408"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050646"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.9.4356-4363.1990"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-65-8-1261"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-66-9-1969"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-68-12-3105"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-6-1605"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1997.tb01013.x"},{"key":"e_1_3_2_27_2","first-page":"191","volume":"260","year":"2001","unstructured":"Griffin, D. E., S. Ubol, P. Despres, T. Kimura, and A. Byrnes. 2001 . Role of antibodies in controlling alphavirus infection of neurons. Curr. Top. Microbiol. Immunol.260:191-200.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_4.S830"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1980.29.638"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4049\/jimmunol.132.3.1529","volume":"132","year":"1984","unstructured":"Halstead, S. B., C. N. Venkateshan, M. K. Gentry, and L. K. Larsen. 1984. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.J. Immunol.132:1529-1532.","journal-title":"J. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2002.01014.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-8-2101"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0505.990505"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/315847"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","volume":"141","year":"1988","unstructured":"Kimura-Kuroda, J., and K. Yasui. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol.141:3606-3610.","journal-title":"J. Immunol."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.4.2921-2927.1997"},{"key":"e_1_3_2_37_2","first-page":"121","volume":"4","year":"1992","unstructured":"Kurane, I., and F. E. Ennis. 1992. Immunity and immunopathology in dengue virus infections. Semin. Immunol.4:121-127.","journal-title":"Semin. Immunol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.11.6429-6435.1992"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(94)90341-7"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1658936"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4049\/jimmunol.132.3.1533","volume":"132","year":"1984","unstructured":"Mathews, J. H., and J. T. Roehrig. 1984. Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J. Immunol.132:1533-1537.","journal-title":"J. Immunol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.3.500"},{"key":"e_1_3_2_43_2","first-page":"443","volume":"46","year":"1965","unstructured":"Nir, Y., A. Beemer, and R. A. Goldwasser. 1965. West Nile Virus infection in mice following exposure to a viral aerosol. Br. J. Exp. Pathol.46:443-449.","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(73)90100-7"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/282509a0"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/289189a0"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-58-2-283"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01310983"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90317-I"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01314128"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-8-1697"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(83)90323-9"},{"key":"e_1_3_2_53_2","first-page":"286","year":"2001","unstructured":"Roehrig, J. T., L. A. Staudinger, A. R. Hunt, J. H. Mathews, and C. D. Blair. 2001 . Antibody prophylaxis and therapy for flaviviral encephalitis infections. Ann. N. Y. Acad. Sci. 951:286-297.","journal-title":"Ann. N. Y. Acad. Sci. 951:"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(00)00111-X"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.60.3.1153-1155.1986"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-3-593"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","volume":"135","year":"1985","unstructured":"Schlesinger, J. J., M. W. Brandriss, and E. E. Walsh. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol.135:2805-2809.","journal-title":"J. Immunol."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-68-3-853"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-1-217"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1015"},{"key":"e_1_3_2_61_2","first-page":"85","volume":"85","year":"1991","unstructured":"Sharma, S., A. Mathur, V. Prakash, R. Kulshreshtha, R. Kumar, and U. C. Chaturvedi. 1991. Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin. Exp. Immunol.85:85-89.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_62_2","first-page":"759","volume":"7","year":"2001","unstructured":"Shimoni, Z., M. J. Niven, S. Pitlick, and S. Bulvik. 2001 . Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg. Infect. Dis.7:759.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.6.2232-2239.2000"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03538-7"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00515-1"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400041218"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0704.017420"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0501.990107"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.24.12941-12949.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.24.12941-12949.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:48:19Z","timestamp":1704984499000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.77.24.12941-12949.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,15]]},"references-count":67,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2003,12,15]]}},"alternative-id":["10.1128\/JVI.77.24.12941-12949.2003"],"URL":"https:\/\/doi.org\/10.1128\/jvi.77.24.12941-12949.2003","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,15]]},"assertion":[{"value":"2003-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-09-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}